The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 08, 2010
Filed:
Aug. 07, 2007
Katsumi Maezono, Kawasaki, JP;
Toshihiko Yoshimura, Kawasaki, JP;
Nozomu Ishida, Kawasaki, JP;
Naoyuki Fukuchi, Kawasaki, JP;
Toshihiro Hatanaka, Kawasaki, JP;
Osamu Ikehara, Kawasaki, JP;
Yayoi Kawato, Kawasaki, JP;
Hideyuki Tanaka, Kawasaki, JP;
Katsumi Maezono, Kawasaki, JP;
Toshihiko Yoshimura, Kawasaki, JP;
Nozomu Ishida, Kawasaki, JP;
Naoyuki Fukuchi, Kawasaki, JP;
Toshihiro Hatanaka, Kawasaki, JP;
Osamu Ikehara, Kawasaki, JP;
Yayoi Kawato, Kawasaki, JP;
Hideyuki Tanaka, Kawasaki, JP;
Ajinomoto Co., Inc., Tokyo, JP;
Abstract
The present invention provides an acylamide compound of the following formula (1), prodrugs thereof, or pharmaceutically acceptable salts thereof; and an adiponectin inducer or secretagogue, therapeutic agent of metabolic syndromes, therapeutic agent of hypoadiponectinemia, therapeutic agent of hyperlipemia, preventive/therapeutic agent of diabetes, improving agent of impaired glucose tolerance, improving agent of insulin resistance, enhancing agent of insulin sensitivity, therapeutic agent of hypertension, preventive/therapeutic agent of vascular disorders, an anti-inflammatory agent, therapeutic agent of hepatic inflammation, therapeutic agent of fatty liver, therapeutic agent of hepatic fibrosis, therapeutic agent of liver cirrhosis, preventive/therapeutic agent of non-alcoholic/nonviral steatohepatitis (NASH) or non-alcoholic/nonviral fatty liver disease (NAFLD), or therapeutic agent of obesity, each of which has the above compounds as an active ingredient.